Ignite Creation Date:
2024-05-06 @ 6:58 PM
Last Modification Date:
2024-10-26 @ 2:57 PM
Study NCT ID:
NCT05841147
Status:
RECRUITING
Last Update Posted:
2023-05-03
First Post:
2023-04-21
Brief Title:
Reduction of Microembolism After the Intervention Surgery of Intracranial Aneurysms by Administration of Tirofiban
Sponsor:
Lu Hua
Organization:
The First Affiliated Hospital with Nanjing Medical University
Study Overview
Official Title:
Reduction of Microembolism After Stent-Assisted Coil Embolization of Unruptured Intracranial Aneurysms by Administration of TirofibanA Randomized Controlled Double-blind Trial
Status:
RECRUITING
Status Verified Date:
2023-04
Last Known Status:
None
Delayed Posting:
No
If Stopped, Why?:
Not Stopped
Has Expanded Access:
False
If Expanded Access, NCT#:
N/A
Has Expanded Access, NCT# Status:
N/A
Acronym:
None
Brief Summary:
The goal of this clinical trial is to investigate whether intravenous injection of tilofiban can reduce microembolism in patients with unruptured intracranial aneurysms after Stent-Assisted Coil EmbolizationThe main questions it aims to answer are
Is it safe to inject tirofiban intravenously during interventional treatment of intracranial aneurysms
What dose of tirofiban is safe and effective
Is it safe to inject tirofiban intravenously during interventional treatment of intracranial aneurysms
What dose of tirofiban is safe and effective
Detailed Description:
We aim to reduce microembolism in patients with unruptured intracranial aneurysms after Stent-Assisted Coil Embolization
Study Oversight
Has Oversight DMC:
None
Is a FDA Regulated Drug?:
False
Is a FDA Regulated Device?:
False
Is an Unapproved Device?:
None
Is a PPSD?:
None
Is a US Export?:
None
Is an FDA AA801 Violation?:
None